Fallbasierte Vorstellung der S2e-Leitlinie Diagnostik und Therapie des benignen Prostatasyndroms (BPS)

DOI: 10.1007/s00120-024-02327-1 Publication Date: 2024-04-10T14:03:34Z
ABSTRACT
Benign prostatic hyperplasia (BPH) is the most common disease of lower urinary tract in men. The prevalence increases continuously with increasing age and a chronic progressive course to be expected. In order reduce morbidity affected patients improve their quality life, expert panel Prostatic Hyperplasia German Society Urology (DGU) has written new version evidence-based "S2e guideline on diagnosis treatment BPH". Using current patient case, contents S2e are illustrated, from decision-making process for suitable choice. case presented here shows possible complexity difficulty that can arise BPH, need further diagnostic steps finding therapy fulfill patient's wishes, if possible.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (1)